Matinas BioPharma Holdings EV 2011-2026 | MTNB

EV Jährlich Matinas BioPharma Holdings

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
346 K	2.68 M	98.9 M	200 M	285 M	185 M	87.5 M	100 M	124 M	30 M	14.6 M	-9.98 M	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
285 M	-9.98 M	93.3 M

EV anderer Aktien in der Pharmaeinzelhändler

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	1.82 B	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	436 M	-	1052.0 %	$ 415 M	USA
Veracyte VCYT	2.78 B	$ 31.01	-5.46 %	$ 2.44 B	USA
Aeterna Zentaris AEZS	5.52 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	3.93 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-23.2 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	22.8 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	95.1 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	2.99 B	-	-	$ 3.67 B	USA
I-Mab IMAB	8.28 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.95 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	168 B	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	417 M	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	525 M	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	4.02 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-18.3 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.79 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	3.41 B	-	-1.52 %	$ 24.7 M	USA
Vir Biotechnology VIR	1.02 B	$ 8.47	-5.47 %	$ 1.17 B	USA
Arena Pharmaceuticals ARNA	5.65 B	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-9.16 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-1.23 M	-	-52.27 %	$ 4.45 M	USA
Viking Therapeutics VKTX	3.09 B	$ 32.67	-4.61 %	$ 3.68 B	USA
Ayala Pharmaceuticals AYLA	5.32 M	-	-	$ 7.46 M	Israel
Atreca BCEL	94.8 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	-13.2 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	270 M	-	-	$ 546 M	USA
Viridian Therapeutics VRDN	2.95 B	$ 27.39	-2.87 %	$ 2.79 B	USA
Acasti Pharma ACST	24 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	14.1 M	-	-	-	Russia
Vertex Pharmaceuticals Incorporated VRTX	127 B	$ 437.99	-3.47 %	$ 112 B	USA
Avid Bioservices CDMO	661 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	125 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	38.2 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-3.02 M	-	-9.65 %	$ 45.9 M	USA
Verastem VSTM	388 M	$ 5.01	-5.29 %	$ 347 M	USA
VistaGen Therapeutics VTGN	20.3 M	$ 0.56	-7.23 %	$ 17.3 M	USA
Adaptive Biotechnologies Corporation ADPT	2.7 B	$ 12.88	-7.74 %	$ 1.95 B	USA
vTv Therapeutics VTVT	15.3 M	$ 38.69	2.35 %	$ 152 M	USA
Voyager Therapeutics VYGR	232 M	$ 3.97	-4.0 %	$ 233 M	USA
BeiGene, Ltd. BGNE	-720 M	-	0.49 %	$ 251 B	Cayman-islands
Alnylam Pharmaceuticals ALNY	43.3 B	$ 320.49	-2.34 %	$ 42 B	USA
BioDelivery Sciences International BDSI	445 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	71.1 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	91.4 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	122 M	$ 1.07	-1.82 %	$ 21.9 M	Israel
Enochian Biosciences ENOB	145 M	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	3.19 B	-	-	$ 867 M	Germany
Equillium EQ	91.1 M	$ 1.93	-6.31 %	$ 111 M	USA
Amgen AMGN	189 B	$ 351.01	-0.61 %	$ 189 B	USA